Cannabis Market By Product Type, By Compound, By Application: Global Opportunity Analysis and Industry Forecast, 2021-2031

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
3.7. Value Chain Analysis
3.8. Market Share Analysis

CHAPTER 4: CANNABIS MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Buds or Marijuana Flower
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Cannabis Extracts
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country

CHAPTER 5: CANNABIS MARKET, BY COMPOUND
5.1 Overview
5.1.1 Market size and forecast
5.2 THC-dominant
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Balanced THC and CBD
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 CBD-dominant
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country

CHAPTER 6: CANNABIS MARKET, BY APPLICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Medical
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Recreational
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country

CHAPTER 7: CANNABIS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product Type
7.2.3 North America Market size and forecast, by Compound
7.2.4 North America Market size and forecast, by Application
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product Type
7.2.5.1.2 Market size and forecast, by Compound
7.2.5.1.3 Market size and forecast, by Application
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product Type
7.2.5.2.2 Market size and forecast, by Compound
7.2.5.2.3 Market size and forecast, by Application
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product Type
7.2.5.3.2 Market size and forecast, by Compound
7.2.5.3.3 Market size and forecast, by Application
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product Type
7.3.3 Europe Market size and forecast, by Compound
7.3.4 Europe Market size and forecast, by Application
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product Type
7.3.5.1.2 Market size and forecast, by Compound
7.3.5.1.3 Market size and forecast, by Application
7.3.5.2 Italy
7.3.5.2.1 Market size and forecast, by Product Type
7.3.5.2.2 Market size and forecast, by Compound
7.3.5.2.3 Market size and forecast, by Application
7.3.5.3 Denmark
7.3.5.3.1 Market size and forecast, by Product Type
7.3.5.3.2 Market size and forecast, by Compound
7.3.5.3.3 Market size and forecast, by Application
7.3.5.4 Poland
7.3.5.4.1 Market size and forecast, by Product Type
7.3.5.4.2 Market size and forecast, by Compound
7.3.5.4.3 Market size and forecast, by Application
7.3.5.5 UK
7.3.5.5.1 Market size and forecast, by Product Type
7.3.5.5.2 Market size and forecast, by Compound
7.3.5.5.3 Market size and forecast, by Application
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product Type
7.3.5.6.2 Market size and forecast, by Compound
7.3.5.6.3 Market size and forecast, by Application
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product Type
7.4.3 Asia-Pacific Market size and forecast, by Compound
7.4.4 Asia-Pacific Market size and forecast, by Application
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Thailand
7.4.5.1.1 Market size and forecast, by Product Type
7.4.5.1.2 Market size and forecast, by Compound
7.4.5.1.3 Market size and forecast, by Application
7.4.5.2 Australia
7.4.5.2.1 Market size and forecast, by Product Type
7.4.5.2.2 Market size and forecast, by Compound
7.4.5.2.3 Market size and forecast, by Application
7.4.5.3 New Zealand
7.4.5.3.1 Market size and forecast, by Product Type
7.4.5.3.2 Market size and forecast, by Compound
7.4.5.3.3 Market size and forecast, by Application
7.4.5.4 Rest of Asia-Pacific
7.4.5.4.1 Market size and forecast, by Product Type
7.4.5.4.2 Market size and forecast, by Compound
7.4.5.4.3 Market size and forecast, by Application
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product Type
7.5.3 LAMEA Market size and forecast, by Compound
7.5.4 LAMEA Market size and forecast, by Application
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product Type
7.5.5.1.2 Market size and forecast, by Compound
7.5.5.1.3 Market size and forecast, by Application
7.5.5.2 South Africa
7.5.5.2.1 Market size and forecast, by Product Type
7.5.5.2.2 Market size and forecast, by Compound
7.5.5.2.3 Market size and forecast, by Application
7.5.5.3 Rest of LAMEA
7.5.5.3.1 Market size and forecast, by Product Type
7.5.5.3.2 Market size and forecast, by Compound
7.5.5.3.3 Market size and forecast, by Application

CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES
9.1 Aurora Cannabis Inc.
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Aphria Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Canopy Growth Corporation
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 cresco labs
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Curaleaf Holdings
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Ecofibre Limited
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 green thumb industries (gti)
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Harvest Health and Recreation
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 HEXO Corp.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Indiva
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 Maricann Group Inc.
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
9.12 Medical Marijuana Inc.
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Operating business segments
9.12.4 Product portfolio
9.12.5 Business performance
9.12.6 Key strategic moves and developments
9.13 MedMen
9.13.1 Company overview
9.13.2 Company snapshot
9.13.3 Operating business segments
9.13.4 Product portfolio
9.13.5 Business performance
9.13.6 Key strategic moves and developments
9.14 Organigrams Holding Inc.
9.14.1 Company overview
9.14.2 Company snapshot
9.14.3 Operating business segments
9.14.4 Product portfolio
9.14.5 Business performance
9.14.6 Key strategic moves and developments
9.15 Stenocare
9.15.1 Company overview
9.15.2 Company snapshot
9.15.3 Operating business segments
9.15.4 Product portfolio
9.15.5 Business performance
9.15.6 Key strategic moves and developments

List of Tables
Table 1. Global Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 2. Cannabis Market Size, for Buds or Marijuana Flower, by Region, 2021-2031 ($Million)
Table 3. Cannabis Market for Buds or Marijuana Flower, by Country, 2021-2031 ($Million)
Table 4. Cannabis Market Size, for Cannabis Extracts, by Region, 2021-2031 ($Million)
Table 5. Cannabis Market for Cannabis Extracts, by Country, 2021-2031 ($Million)
Table 6. Global Cannabis Market, by Compound, 2021-2031 ($Million)
Table 7. Cannabis Market Size, for Thc-Dominant, by Region, 2021-2031 ($Million)
Table 8. Cannabis Market for Thc-Dominant, by Country, 2021-2031 ($Million)
Table 9. Cannabis Market Size, for Balanced Thc and Cbd, by Region, 2021-2031 ($Million)
Table 10. Cannabis Market for Balanced Thc and Cbd, by Country, 2021-2031 ($Million)
Table 11. Cannabis Market Size, for Cbd-Dominant, by Region, 2021-2031 ($Million)
Table 12. Cannabis Market for Cbd-Dominant, by Country, 2021-2031 ($Million)
Table 13. Global Cannabis Market, by Application, 2021-2031 ($Million)
Table 14. Cannabis Market Size, for Medical, by Region, 2021-2031 ($Million)
Table 15. Cannabis Market for Medical, by Country, 2021-2031 ($Million)
Table 16. Cannabis Market Size, for Recreational, by Region, 2021-2031 ($Million)
Table 17. Cannabis Market for Recreational, by Country, 2021-2031 ($Million)
Table 18. Cannabis Market Size, for Others, by Region, 2021-2031 ($Million)
Table 19. Cannabis Market for Others, by Country, 2021-2031 ($Million)
Table 20. Cannabis Market, by Region, 2021-2031 ($Million)
Table 21. North America Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 22. North America Cannabis Market, by Compound, 2021-2031 ($Million)
Table 23. North America Cannabis Market, by Application, 2021-2031 ($Million)
Table 24. North America Cannabis Market, by Country, 2021-2031 ($Million)
Table 25. U.S. Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 26. U.S. Cannabis Market, by Compound, 2021-2031 ($Million)
Table 27. U.S. Cannabis Market, by Application, 2021-2031 ($Million)
Table 28. Canada Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 29. Canada Cannabis Market, by Compound, 2021-2031 ($Million)
Table 30. Canada Cannabis Market, by Application, 2021-2031 ($Million)
Table 31. Mexico Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 32. Mexico Cannabis Market, by Compound, 2021-2031 ($Million)
Table 33. Mexico Cannabis Market, by Application, 2021-2031 ($Million)
Table 34. Europe Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 35. Europe Cannabis Market, by Compound, 2021-2031 ($Million)
Table 36. Europe Cannabis Market, by Application, 2021-2031 ($Million)
Table 37. Europe Cannabis Market, by Country, 2021-2031 ($Million)
Table 38. Germany Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 39. Germany Cannabis Market, by Compound, 2021-2031 ($Million)
Table 40. Germany Cannabis Market, by Application, 2021-2031 ($Million)
Table 41. Italy Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 42. Italy Cannabis Market, by Compound, 2021-2031 ($Million)
Table 43. Italy Cannabis Market, by Application, 2021-2031 ($Million)
Table 44. Denmark Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 45. Denmark Cannabis Market, by Compound, 2021-2031 ($Million)
Table 46. Denmark Cannabis Market, by Application, 2021-2031 ($Million)
Table 47. Poland Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 48. Poland Cannabis Market, by Compound, 2021-2031 ($Million)
Table 49. Poland Cannabis Market, by Application, 2021-2031 ($Million)
Table 50. UK Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 51. UK Cannabis Market, by Compound, 2021-2031 ($Million)
Table 52. UK Cannabis Market, by Application, 2021-2031 ($Million)
Table 53. Rest of Europe Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 54. Rest of Europe Cannabis Market, by Compound, 2021-2031 ($Million)
Table 55. Rest of Europe Cannabis Market, by Application, 2021-2031 ($Million)
Table 56. Asia-Pacific Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 57. Asia-Pacific Cannabis Market, by Compound, 2021-2031 ($Million)
Table 58. Asia-Pacific Cannabis Market, by Application, 2021-2031 ($Million)
Table 59. Asia-Pacific Cannabis Market, by Country, 2021-2031 ($Million)
Table 60. Thailand Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 61. Thailand Cannabis Market, by Compound, 2021-2031 ($Million)
Table 62. Thailand Cannabis Market, by Application, 2021-2031 ($Million)
Table 63. Australia Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 64. Australia Cannabis Market, by Compound, 2021-2031 ($Million)
Table 65. Australia Cannabis Market, by Application, 2021-2031 ($Million)
Table 66. New Zealand Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 67. New Zealand Cannabis Market, by Compound, 2021-2031 ($Million)
Table 68. New Zealand Cannabis Market, by Application, 2021-2031 ($Million)
Table 69. Rest of Asia-Pacific Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 70. Rest of Asia-Pacific Cannabis Market, by Compound, 2021-2031 ($Million)
Table 71. Rest of Asia-Pacific Cannabis Market, by Application, 2021-2031 ($Million)
Table 72. LAMEA Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 73. LAMEA Cannabis Market, by Compound, 2021-2031 ($Million)
Table 74. LAMEA Cannabis Market, by Application, 2021-2031 ($Million)
Table 75. LAMEA Cannabis Market, by Country, 2021-2031 ($Million)
Table 76. Brazil Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 77. Brazil Cannabis Market, by Compound, 2021-2031 ($Million)
Table 78. Brazil Cannabis Market, by Application, 2021-2031 ($Million)
Table 79. South Africa Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 80. South Africa Cannabis Market, by Compound, 2021-2031 ($Million)
Table 81. South Africa Cannabis Market, by Application, 2021-2031 ($Million)
Table 82. Rest of LAMEA Cannabis Market, by Product Type, 2021-2031 ($Million)
Table 83. Rest of LAMEA Cannabis Market, by Compound, 2021-2031 ($Million)
Table 84. Rest of LAMEA Cannabis Market, by Application, 2021-2031 ($Million)
Table 85. Aurora Cannabis Inc.: Company Snapshot
Table 86. Aurora Cannabis Inc.: Operating Segments
Table 87. Aurora Cannabis Inc.: Product Portfolio
Table 88. Aurora Cannabis Inc.: Net Sales
Table 89. Aurora Cannabis Inc.: Key Strategies
Table 90. Aphria Inc.: Company Snapshot
Table 91. Aphria Inc.: Operating Segments
Table 92. Aphria Inc.: Product Portfolio
Table 93. Aphria Inc.: Net Sales
Table 94. Aphria Inc.: Key Strategies
Table 95. Canopy Growth Corporation: Company Snapshot
Table 96. Canopy Growth Corporation: Operating Segments
Table 97. Canopy Growth Corporation: Product Portfolio
Table 98. Canopy Growth Corporation: Net Sales
Table 99. Canopy Growth Corporation: Key Strategies
Table 100. Cresco Labs: Company Snapshot
Table 101. Cresco Labs: Operating Segments
Table 102. Cresco Labs: Product Portfolio
Table 103. Cresco Labs: Net Sales
Table 104. Cresco Labs: Key Strategies
Table 105. Curaleaf Holdings: Company Snapshot
Table 106. Curaleaf Holdings: Operating Segments
Table 107. Curaleaf Holdings: Product Portfolio
Table 108. Curaleaf Holdings: Net Sales
Table 109. Curaleaf Holdings: Key Strategies
Table 110. Ecofibre Limited: Company Snapshot
Table 111. Ecofibre Limited: Operating Segments
Table 112. Ecofibre Limited: Product Portfolio
Table 113. Ecofibre Limited: Net Sales
Table 114. Ecofibre Limited: Key Strategies
Table 115. Green Thumb Industries (Gti): Company Snapshot
Table 116. Green Thumb Industries (Gti): Operating Segments
Table 117. Green Thumb Industries (Gti): Product Portfolio
Table 118. Green Thumb Industries (Gti): Net Sales
Table 119. Green Thumb Industries (Gti): Key Strategies
Table 120. Harvest Health and Recreation: Company Snapshot
Table 121. Harvest Health and Recreation: Operating Segments
Table 122. Harvest Health and Recreation: Product Portfolio
Table 123. Harvest Health and Recreation: Net Sales
Table 124. Harvest Health and Recreation: Key Strategies
Table 125. Hexo Corp.: Company Snapshot
Table 126. Hexo Corp.: Operating Segments
Table 127. Hexo Corp.: Product Portfolio
Table 128. Hexo Corp.: Net Sales
Table 129. Hexo Corp.: Key Strategies
Table 130. Indiva: Company Snapshot
Table 131. Indiva: Operating Segments
Table 132. Indiva: Product Portfolio
Table 133. Indiva: Net Sales
Table 134. Indiva: Key Strategies
Table 135. Maricann Group Inc.: Company Snapshot
Table 136. Maricann Group Inc.: Operating Segments
Table 137. Maricann Group Inc.: Product Portfolio
Table 138. Maricann Group Inc.: Net Sales
Table 139. Maricann Group Inc.: Key Strategies
Table 140. Medical Marijuana Inc.: Company Snapshot
Table 141. Medical Marijuana Inc.: Operating Segments
Table 142. Medical Marijuana Inc.: Product Portfolio
Table 143. Medical Marijuana Inc.: Net Sales
Table 144. Medical Marijuana Inc.: Key Strategies
Table 145. Medmen: Company Snapshot
Table 146. Medmen: Operating Segments
Table 147. Medmen: Product Portfolio
Table 148. Medmen: Net Sales
Table 149. Medmen: Key Strategies
Table 150. Organigrams Holding Inc.: Company Snapshot
Table 151. Organigrams Holding Inc.: Operating Segments
Table 152. Organigrams Holding Inc.: Product Portfolio
Table 153. Organigrams Holding Inc.: Net Sales
Table 154. Organigrams Holding Inc.: Key Strategies
Table 155. Stenocare: Company Snapshot
Table 156. Stenocare: Operating Segments
Table 157. Stenocare: Product Portfolio
Table 158. Stenocare: Net Sales
Table 159. Stenocare: Key Strategies

List of Figures
Figure 1. Cannabis Market Segmentation
Figure 2. Cannabis Market, 2021-2031
Figure 3. Cannabis Market, 2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Cannabis Mark.:Drivers, Restraints and Opportunities
Figure 12. Value Chain Analysis
Figure 13. Market Share Analysis
Figure 14. Cannabis Market, By Product Type, 2021(%)
Figure 15. Comparative Share Analysis of Buds or Marijuana Flower Cannabis Market, 2021-2031(%)
Figure 16. Comparative Share Analysis of Cannabis Extracts Cannabis Market, 2021-2031(%)
Figure 17. Cannabis Market, By Compound, 2021(%)
Figure 18. Comparative Share Analysis of Thc-Dominant Cannabis Market, 2021-2031(%)
Figure 19. Comparative Share Analysis of Balanced Thc and Cbd Cannabis Market, 2021-2031(%)
Figure 20. Comparative Share Analysis of Cbd-Dominant Cannabis Market, 2021-2031(%)
Figure 21. Cannabis Market, By Application, 2021(%)
Figure 22. Comparative Share Analysis of Medical Cannabis Market, 2021-2031(%)
Figure 23. Comparative Share Analysis of Recreational Cannabis Market, 2021-2031(%)
Figure 24. Comparative Share Analysis of Others Cannabis Market, 2021-2031(%)
Figure 25. Cannabis Market by Region, 2021
Figure 26. U.S. Cannabis Market, 2021-2031($Million)
Figure 27. Canada Cannabis Market, 2021-2031($Million)
Figure 28. Mexico Cannabis Market, 2021-2031($Million)
Figure 29. Germany Cannabis Market, 2021-2031($Million)
Figure 30. Italy Cannabis Market, 2021-2031($Million)
Figure 31. Denmark Cannabis Market, 2021-2031($Million)
Figure 32. Poland Cannabis Market, 2021-2031($Million)
Figure 33. Uk Cannabis Market, 2021-2031($Million)
Figure 34. Rest of Europe Cannabis Market, 2021-2031($Million)
Figure 35. Thailand Cannabis Market, 2021-2031($Million)
Figure 36. Australia Cannabis Market, 2021-2031($Million)
Figure 37. New Zealand Cannabis Market, 2021-2031($Million)
Figure 38. Rest of Asia-Pacific Cannabis Market, 2021-2031($Million)
Figure 39. Brazil Cannabis Market, 2021-2031($Million)
Figure 40. South Africa Cannabis Market, 2021-2031($Million)
Figure 41. Rest of LAMEA Cannabis Market, 2021-2031($Million)
Figure 42. Top Winning Strategies, by Year
Figure 43. Top Winning Strategies, by Development
Figure 44. Top Winning Strategies, by Company
Figure 45. Product Mapping of Top 10 Players
Figure 46. Competitive Dashboard
Figure 47. Competitive Heatmap of Top 10 Key Players
Figure 48. Aurora Cannabis Inc.: Net Sales, ($Million)
Figure 49. Aphria Inc.: Net Sales, ($Million)
Figure 50. Canopy Growth Corporatio.: Net Sales, ($Million)
Figure 51. Cresco Lab.: Net Sales, ($Million)
Figure 52. Curaleaf Holding.: Net Sales, ($Million)
Figure 53. Ecofibre Limite.: Net Sales, ($Million)
Figure 54. Green Thumb Industries (Gti.: Net Sales, ($Million)
Figure 55. Harvest Health and Recreatio.: Net Sales, ($Million)
Figure 56. Hexo Corp.: Net Sales, ($Million)
Figure 57. Indiv.: Net Sales, ($Million)
Figure 58. Maricann Group Inc.: Net Sales, ($Million)
Figure 59. Medical Marijuana Inc.: Net Sales, ($Million)
Figure 60. Medme.: Net Sales, ($Million)
Figure 61. Organigrams Holding Inc.: Net Sales, ($Million)
Figure 62. Stenocar.: Net Sales, ($Million)

Executive Summary

According to the report, “Cannabis Market," the cannabis market size was valued at $25.7 billion in 2021, and is estimated to reach $148.9 billion by 2031, growing at a CAGR of 20.1% from 2022 to 2031.

For the treatment of a number of disorders, doctors recommend cannabis, often known as marijuana. Due to production and political constraints, the use of cannabis as medicine has not undergone extensive testing, which has limited the amount of clinical research that can be done to determine the safety and effectiveness of utilizing cannabis to treat ailments.

The key factors driving the cannabis market growth are the legalization of marijuana in many different countries, the rise in consumer knowledge of the drug's health advantages, and its expanding medicinal uses, including the treatment of a wide range of ailments and symptoms. The medicinal cannabis business is also expanding as a result of increased R&D activity and the creation of novel products. The market's expansion is hampered by a number of major issues, including a complex legislative framework for cannabis use and cannabis' societal stigma. Instead, the Asia-Pacific region's legalization of cannabis presents a business opportunity for the industry's producers.

According to cannabis market analysis, the global cannabis market is analyzed on the basis of product type, compound, application, and region. By product type, the market is divided into buds or marijuana flower and cannabis extracts. Among these, the cannabis extracts segment occupied the major cannabis market share of the market in 2021, and is projected to maintain its dominance during the cannabis market forecast period. Cannabis extracts are concentrates created using a solvent. The terms "extract" and "concentrate" are occasionally used synonymously, despite the fact that this is erroneous. All extracts are concentrates, but not all concentrates are extracts. Butane, propane, ethanol, and supercritical carbon dioxide are the most typical solvents utilized to create a cannabis extract (CO2). All these cannabis market trends are creating cannabis market opportunities.

By compound, the cannabis market is divided into THC-dominant, balanced THC & CBD, and CBD-dominant. The CBD-dominant segment is growing at a moderate rate during the forecast period. Cannabidiol, or CBD, is the second most common active component in marijuana (marijuana). While CBD is a crucial component of medicinal marijuana, it is either produced in a lab or is taken straight from the hemp plant, a relative of the marijuana plant.

By application, it is classified into medical, recreational, and others. The recreational segment is anticipated to grow at highest CAGR during the forecast period. Cannabis is used recreationally when it is consumed for pleasure rather than for medical reasons. The use of marijuana for medicinal purposes, which entails using the drug as directed to treat certain medical diseases' symptoms, can be contrasted with marijuana use for recreational purposes.

The region that dominated the global cannabis market in 2021 was North America, and this dominance is anticipated to continue throughout the forecast period. This was attributed to the legalization of cannabis for medical and recreational use in both the U.S. and Canada, as well as the rise in the use of medical cannabis in North America to treat a number of diseases linked to changing lifestyles, including epilepsy, cancer, multiple sclerosis, post-traumatic stress disorder, chronic pain, depression, and social anxiety. A further factor supporting the expansion of the market in the region was continued R&D in cannabis's recreational uses.

Exporters in both developed and developing nations faced a number of difficulties as a result of the COVID-19 epidemic. The implementation of lockdown and curfew procedures on a global scale had an impact on both domestic and foreign manufacture of cannabis, which in turn hindered market expansion. As a result, the COVID-19 epidemic had a negative influence on the cannabis market in 2020 as a result of decreased company sales and operations being suspended.

The major players analyzed for global cannabis industry are Aurora Cannabis Inc., Tilray, Canopy Growth Corporation, Cresco Labs, Curaleaf, Ecofibre Limited, Green Thumb Industries, Hexo Corporation, INDIVA, Maricann Inc., Medical Marijuana Inc., MME LLC., Organigram Holdings Inc., Stencocare, and Harvest Health & Recreation, Inc.

KEY FINDINGS OF STUDY

• By product type, the cannabis extracts segment was the highest revenue contributor to the market, with $13,794.3 million in 2021, and is estimated to reach $82,309.1 million by 2031, with a CAGR of 20.4%.
• By compound, the balanced THC and CBD segment was the highest revenue contributor to the market, with $11,976.5 million in 2021, and is estimated to reach $67,909.8 million by 2031, with a CAGR of 19.8%.
• Depending on application, the recreational segment was the highest revenue contributor to the market, with $13,873.2 million in 2021, and is estimated to reach $78,013.0 million by 2031, with a CAGR of 19.7%.
• Region wise, North America was the highest revenue contributor, accounting for $22,115.3 million in 2021, and is estimated to reach $104,403.3 million by 2031, with a CAGR of 17.6%.

Companies Mentioned

• Aurora Cannabis Inc.
• Tilray
• Canopy Growth Corporation
• Cresco Labs
• Curaleaf
• Ecofibre Limited
• Green Thumb Industries
• HEXO Corp.
• INDIVA
• Maricann Inc.
• medical marijuana inc.
• MME, LLC.
• Organigram Holdings Inc.
• Stenocare
• Harvest Health & Recreation, Inc

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

• Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
• Scientific and technical writings for product information and related preemptions
• Regional government and statistical databases for macro analysis
• Authentic news articles and other related releases for market evaluation
• Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.